FOXO4-DRI
Also known as: Proxofim, FOXO4 D-retro-inverso
Molecular Overview
FOXO4-DRI is a designer peptide studied in preclinical senescence models for selective interference with FOXO4-p53 binding.
Mechanistic Background
D-amino-acid retro-inverso design competes with native FOXO4 for p53 binding in cell and rodent models.
What Researchers Study
Academic senolytic-model publications since 2017.
Evidence Landscape
Current evidence level: PRECLINICAL. Preclinical evidence does not equate to demonstrated human efficacy.
Research Limitations
No human data; experimental tool compound only.
Scientific References
Research Use Only
Molecularix Biolabs provides research materials for legitimate laboratory research. Information in this Research Library is provided for educational and scientific reference purposes and is not medical advice, treatment guidance, or a recommendation for human or veterinary use.